Research press release


Nature Medicine

Visualizing the tumor cell



Garry Nolanたちは、新しい分析方法を開発してマルチプレックスイオンビーム画像化法(MIBI)と名付けた。この方法は、臨床施設で広く使われている標準的なホルマリン固定したパラフィン埋め込み型腫瘍組織切片を用いて、同時に多数の分子マーカーを高感度で解析できる。NolanたちはこのMIBIを用いて、臨床的に重要な金属結合抗体で染色した乳がん組織切片の画像化を行い、この技術が診断に役立つ可能性があることを実証した。


An imaging approach that allows for the simultaneous visualization of up to 100 clinically relevant metal isotope-labeled antibodies in human breast tumors from tissue sections is reported this week in Nature Medicine. This technique provides important and accurate information about disease pathogenesis that may help with clinical diagnosis.

Immunohistochemistry and immunofluorescence are tools that visualize proteins using colored pigments and fluorescence signals and that have been the cornerstone of clinical diagnostics involving tissue sections. However, technical and practical shortcomings have limited their use. In particular, these methods are not appropriate for quantitatively analyzing multiple antigens expressed in tissues or cells, which is often needed to understand the molecular and morphological features of clinical biopsies.

Garry Nolan and colleagues developed a method called multiplexed ion beam imaging (MIBI) that allows with high sensitivity the analysis of numerous molecular markers at the same time using standard formalin-fixed, paraffin-embedded tumor tissue sections, which are commonly used in the clinic. Using MIBI, the authors imaged breast tumor tissue sections stained with clinically relevant metal-conjugated antibodies to demonstrate that the technique may be useful in a diagnosis setting.

The approach can provide new insights into disease pathogenesis, tumor heterogeneity and pathway activation status at the single-cell level, and aid in the classification of cancer patients, although some limitations still exist regarding its use in the clinic for diagnostic purposes.

doi: 10.1038/nm.3488


メールマガジンリストの「Nature 関連誌今週のハイライト」にチェックをいれていただきますと、毎週各ジャーナルからの最新の「注目のハイライト」をまとめて皆様にお届けいたします。